Mahavir Agarwal
University of Toronto
H-index: 25
North America-Canada
Top articles of Mahavir Agarwal
454. Elevated Intrinsic Cortical Curvature in Treatment-Resistant Schizophrenia: Structural Deformation of Functional Activity Areas
Biological Psychiatry
2024/5/15
389. The Anxiolytic Effect of Atypical Antipsychotics in Patients With Schizophrenia: A Systematic Review and Meta-Analysis
2024/5/15
413. Identifying Predictors of Clozapine-Induced Weight Gain Through a Naturalistic Retrospective Chart Review
Biological Psychiatry
2024/5/15
Neurocognitive correlates of metabolic dysregulation in individuals with mood disorders: a systematic review and meta-analysis
2024/3/7
Olanzapine’s effects on hypothalamic transcriptomics and kinase activity
Psychoneuroendocrinology
2024/2/6
Safety of BEN guidelines in clozapine treatment: A Canadian perspective
Schizophrenia Research
2024/2/1
Evenamide: a potential pharmacotherapeutic alternative for treatment-resistant schizophrenia
International Journal of Neuropsychopharmacology
2024/2/1
Glucose dysregulation in antipsychotic-naive first-episode psychosis: in silico exploration of gene expression signatures
Translational Psychiatry
2024/1/10
Central insulin dysregulation in antipsychotic-naïve first-episode psychosis: In silico exploration of gene expression signatures
Psychiatry Research
2024/1/1
Depression in caregivers of patients with schizophrenia: a scoping review
2024/1
Technology-Enabled Collaborative Care for concurrent diabetes and distress management during the COVID-19 pandemic: Protocol for a mixed methods feasibility study
JMIR Research Protocols
2023/1/17
Duration and Frequency Mismatch Negativity in Schizophrenia, Unaffected first-degree relatives, and Healthy controls
medRxiv
2023
Addressing metabolic comorbidity in individuals with intellectual and developmental disability on antipsychotics: a clinical case series
Journal of Clinical Psychopharmacology
2023/1/1
Promising translatable pharmacological interventions for body weight management in individuals with severe mental illness–a narrative review
2023/11/2
Management of dyslipidaemia in individuals with severe mental illness: a population-based study in the Greater Copenhagen Area
Therapeutic Advances in Psychopharmacology
2023/11
Antipsychotic-Induced Weight Gain in Severe Mental Illness: Risk Factors and Special Considerations
2023/11
Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocol
Plos one
2023/9/21
Ofer Agid
H-Index: 36
Araba Chintoh
H-Index: 15
Andreea Diaconescu
H-Index: 14
Philip Gerretsen
H-Index: 24
James L Kennedy
H-Index: 67
Nicole Kozloff
H-Index: 14
Farooq Naeem
H-Index: 25
Nicholas Neufeld
H-Index: 10
Martin Rotenberg
H-Index: 3
Peter Selby
H-Index: 33
Wei Wang
H-Index: 14
Robert Zipursky
H-Index: 37
Margaret Hahn
H-Index: 21
Clinical Improvement in Schizophrenia During Antipsychotic Treatment in Relation to Changes in Glucose Parameters: A Systematic Review
2023/9/7
Favourable cognitive changes observed with metabolic improvements in a patient with severe mental illness
Journal of Psychiatry and Neuroscience
2023/9/6
Pharmacological interventions for the prevention of antipsychotic-induced weight gain in people with schizophrenia: a Cochrane systematic review and meta-analysis
2024